CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54

Coriolis

About Coriolis

Coriolis Pharma is a globally operating contract research organization (CRO) and a leader in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines.

Founded in 2008, Coriolis is the expert for early and late-stage biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical method development under R&D and GMP. Non-GMP manufacturing services for a wide range of products complete the service portfolio.

Certifications

GMP

Sales Markets

East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania

Categories

Coriolis

DE
2022

On CPHI since
1

Certificates
100 - 249

Employees

Compare

Add to favorites Added to favorites

Company types

Contract Research Organisation (CRO)

Primary activities

Analytical Services

Biopharmaceutical

Contract Research Organisation

Laboratory Services

Contact info

+49 89 41 77 60-0
Website
Fraunhofer Straße 18b, 82152, Martinsried, Munich, Germany

Meet us at

CPHI Milan 2024

Fiera Milano, Italy

08 Oct 2024 - 10 Oct 2024

View Exhibitor Profile

Products from Coriolis (3)

Product Drug Product Development

We support our clients from early-stage research and preclinical phase to and beyond market approval by providing comprehensive development services, including

• Developability assessment • Pre-formulation screening • Formulation development • Lyophilization process development • Forced d...

Compare
Product Analytical Services (up to GMP)

Our analytical portfolio comprises 100+ different techniques – all performed by Coriolis’ experts in-house. Our offering includes:
• Aggregate analytics • Particle characterization • Particle identification • Surfactant characterization • Higher order structure analysis • Funcional assays • Chemi...

Compare
Product Manufacturing Support

We support our clients with the production of non-GMP drug product batches for preclinical and indicative stability studies, including
• Liquid drug product manufacturing • Lyophilized drug product manufacturing • Analytics and stability testing

Compare

Coriolis Resources (2)

News Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies

Coriolis Pharma announces the launch of a U.S. entity that allows customers to combine the convenience of a local service with the advantages of international expertise. In parallel Coriolis introduces two novel platform services for developability assessment and pre-formulation screening.

5 Jun 2024
Brochure Coriolis Pharma at a glance

Coriolis is your trusted partner for drug product development and analytical services. Learn more about our expertise and services and see how we can help you with the development of your biopharmaceutical drug product. Let's develop your success together